Why it’s important to review the care of people with dementia: What the data and people’s experiences tell us about social care reviews, reassessments and their outcomes for people with dementia – Healthwatch

This Healthwatch report summarises data and people’s experiences about social care reviews, reassessments and their outcomes for people with dementia. On the basis of analysis of data from 97 local councils, the report finds people are not getting what they

The Impact of Primary Care Incentive Schemes on Care Home Placements for People with Dementia: (CHE Research Paper 164) – University of York Centre for Health Economics

The interface between primary care and long-term care is complex. In the case of dementia, this interface may be influenced by incentives offered to GPs as part of the Quality and Outcomes Framework (QOF) to provide an annual review for

Using the Care Review Tool for mortality reviews in Mental Health Trusts: Guidance for reviewers – Royal College of Psychiatrists

Guidance for NHS mental health trusts to ensure ways of improving services are learned from patients’ deaths is unveiled today.  The guidance, drawn up by the Royal College of Psychiatrists (RCPsych), focuses on patients with severe mental illness and on four

Care review tool for mortality reviews – Royal College of Psychiatrists

Guidance for NHS mental health trusts to ensure ways of improving services are learned from patients’ deaths is unveiled today.  The guidance, drawn up by the Royal College of Psychiatrists (RCPsych), focuses on patients with severe mental illness and on four

How Should Health Policy Respond To The Growing Challenge Of Multimorbidity?: We need patient-centred care, with more emphasis on generalist rather than specialist care and better integration between general practice, hospitals and social care: (Policy Report 39) – University of Bristol, Policy Bristol

The number of people with multiple long-term conditions, known as multimorbidity, is rising internationally, putting increased pressure on health care systems, including the NHS. Researchers from the 3D Study – the largest ever trial of a person-centred approach to caring

Assessing the Preparedness of the Health Care System Infrastructure in Six European Countries for an Alzheimer’s Treatment – RAND Corporation

This research analyzes the preparedness of the health care systems in six European countries — France, Germany, Italy, Spain, Sweden, and the United Kingdom — to ensure timely diagnosis and treatment of patients if a disease-modifying therapy for Alzheimer’s becomes

World Alzheimer Report 2018: The State Of The Art Of Dementia Research: New Frontiers – Alzheimer’s Disease International

Alzheimer’s Disease International report that looks at a broad cross section of research areas including basic science; diagnosis; drug discovery; risk reduction and epidemiology. With the continued absence of a disease modifying treatment, the report also features progress, innovation and developments

Assessment of delirium in hospital for people with dementia: Spotlight audit 2017–2018 – Healthcare Quality Improvement Partnership

The National Audit of Dementia (care in general hospitals) (NAD) examines aspects of care received by people with dementia in general hospitals in England and Wales. In addition, NAD provides national and local reports to support hospitals to identify areas

CPG Hospices and Palliative Care: Inquiry Inequalities in access to hospice and palliative care – Cross Party Group Hospices and Palliative Care

Welsh Assembly Cross Party Group Hospices and Palliative Care report finding people with terminal illnesses and life-limiting conditions in Wales – especially dementia, heart failure and neurological conditions – face a range of barriers in accessing hospice and palliative care. 

Dementia: assessment, management and support for people living with dementia and their carers: NICE guideline [NG97] – NICE

This guideline covers diagnosing and managing dementia (including Alzheimer’s disease). It aims to improve care by making recommendations on training staff and helping carers to support people living with dementia.

Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease: Technology appraisal guidance [TA217] – NICE

Evidence-based recommendations on donepezil (Aricept), galantamine (Reminyl), rivastigmine (Exelon) and memantine (Ebixa) for treating Alzheimer’s disease in adults. This guidance has been partially updated by NICE’s guideline on dementia (NG97) and replaces NICE technology appraisal guidance on donepezil, galantamine, rivastigmine

Dementia and people with learning disabilities: making reasonable adjustments – Public Health England

This guide is part of a series of guides looking at reasonable adjustments in a specific service area.  It is intended to help staff in public health, health services and social care to ensure that their services are accessible to people with learning

Dementia-friendly Rural Communities Guide: A practical guide for rural communities to support people affected by dementia – Alzheimer’s Society

This guide from the Alzheimer’s Society contains information about how dementia affects people’s experience of living and working in a rural community. It provides community-led guidance and signposting to resources to help support people living with dementia and their carers